Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HCC”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04435977
What this trial is testing

Efficacy and Safety of Cabozantinib in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocarcinoma
Istituto Clinico Humanitas 46
Testing effectiveness (Phase 2)Study completedNCT01352728
What this trial is testing

Hepatocellular Carcinoma (HCC) Transarterial Chemoembolisation (TACE) +Axitinib

Who this might be right for
Hepatocellular Carcinoma
Chinese University of Hong Kong 50
Testing effectiveness (Phase 2)Looking for participantsNCT06954467
What this trial is testing

JS207 Combined With JS007 as First-line Treatment for Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Shanghai Junshi Bioscience Co., Ltd. 72
Testing effectiveness (Phase 2)Study completedNCT03516071
What this trial is testing

Brivanib in Chinese Patients With Previously Treated Advanced HCC

Who this might be right for
Hepatocellular Carcinoma (HCC)
Zai Lab (Shanghai) Co., Ltd. 90
Testing effectiveness (Phase 2)Study completedNCT02821754
What this trial is testing

A Pilot Study of Combined Immune Checkpoint Inhibition in Combination With Ablative Therapies in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC)

Who this might be right for
Biliary Tract NeoplasmsLiver CancerHepatocellular Carcinoma+2 more
National Cancer Institute (NCI) 54
Early research (Phase 1)UnknownNCT05363722
What this trial is testing

A Clinical Study to Observe the Effectiveness and Safety of IBI310, Bevacizumab Combined With Sintilimab in the Treatment of Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Shanghai Zhongshan Hospital 80
Testing effectiveness (Phase 2)UnknownNCT06040177
What this trial is testing

Efficacy and Safety of SBRT Combined With Cardonilizumab and Lenvastinib in the Treatment of Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus

Who this might be right for
Hepatocellular Carcinoma Non-resectablePortal Vein Tumor ThrombusImmune Checkpoint Inhibitors
First Affiliated Hospital of Guangxi Medical University 30
Not applicableLooking for participantsNCT07727759
What this trial is testing

CT Volumetry and Hepatic Vascular Deformation Mapping to Predict Post-Hepatectomy Liver Failure

Who this might be right for
Post-Hepatectomy Liver FailureLiver FailureLiver Neoplasms+4 more
Minia University 1,070
Early research (Phase 1)UnknownNCT04823403
What this trial is testing

Hepatic Intra-Arterial Administration of Ipilimumab in Combination With Intra-venous Nivolumab for Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Gustave Roussy, Cancer Campus, Grand Paris 27
Not applicableUnknownNCT05094869
What this trial is testing

Prevention of HCC Using Mobile Phone Applications

Who this might be right for
Liver CirrhosisHepatitis B
Beijing Friendship Hospital 8,000
Testing effectiveness (Phase 2)Ended earlyNCT00667628
What this trial is testing

Phase 2 Study of TAC-101 Combined With Transcatheter Arterial Chemoembolization (TACE) Versus TACE Alone in Japanese Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular Carcinoma
Taiho Oncology, Inc. 54
Large-scale testing (Phase 3)Study completedNCT00149565
What this trial is testing

Phase Ⅲ Randomized Trial in Postoperative Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
National Health Research Institutes, Taiwan 268
Not applicableStudy completedNCT01012011
What this trial is testing

Regulatory Post Marketing Surveillance Study on Nexavar®

Who this might be right for
Carcinoma, HepatocellularCarcinoma, Renal Cell
Bayer 2,845
Not applicableLooking for participantsNCT06549829
What this trial is testing

The Effect of Nutrition-optimized Prehabilitation on Perioperative Intervention in Primary Liver Carcinoma

Who this might be right for
Hepatocellular CarcinomaLiver CarcinomaHepatobiliary Cancers
Second Affiliated Hospital, Zhejiang University, School of Medicine 120
Not applicableStudy completedNCT00820157
What this trial is testing

Cytoreductive Surgery and Transarterial Chemoembolization (TACE) Versus TACE for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital 120
Testing effectiveness (Phase 2)Study completedNCT03380130
What this trial is testing

The Safety and Antitumoral Efficacy of Nivolumab After SIRT for the Treatment of Patients With HCC

Who this might be right for
Hepatocellular Carcinoma
Clinica Universidad de Navarra, Universidad de Navarra 41
Testing effectiveness (Phase 2)UnknownNCT05214339
What this trial is testing

A Trial of Hepatic Arterial Infusion Combined With Bevacizumab and Sintilimab for Unresectable A-staged Hepatocellular Carcinoma in BCLC Classification (D-TRIPLET)

Who this might be right for
Unresectable Hepatocellular CarcinomaHepatocellular Carcinoma by BCLC Stage
Sun Yat-sen University 30
Not applicableStudy completedNCT02113865
What this trial is testing

Score System for Prediction Risk and Early Diagnosis of HCC in HIV/HCV Patients

Who this might be right for
Acquired Immunodeficiency Syndrome VirusHepatitis, Viral, Non-A, Non-B, Parenterally-TransmittedHepatocellular Carcinoma
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 45
Not applicableUnknownNCT02847767
What this trial is testing

Dynamic Contrast Enhanced HCC SABR Liver Study

Who this might be right for
Carcinoma, Hepatocellular
British Columbia Cancer Agency 20
Testing effectiveness (Phase 2)UnknownNCT03447951
What this trial is testing

PTS100 in Primary HCC Patients

Who this might be right for
Hepatocellular Carcinoma
Gongwin Biopharm Co., Ltd. 33
Next Page